Shinva Medical Instrument Co. Ltd. Class A

Shinva Medical Instrument Co. Ltd. Class A

SSSE:600587
12.27
CNY
-0.06
(-0.49%)
0.73EPS
17.52P/E
7.90BMarket Cap
Apr 23Next Earn

Total Valuation

CNY

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A carries a market capitalization of 7.90B, placing it among publicly traded companies globally. Its enterprise value stands at 6.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.90B
Enterprise Value6.28B

Important Dates

Shinva Medical Instrument Co. Ltd. Class A's next confirmed earnings release is scheduled for April 23, 2027.

Earnings Date4/23/2027

Share Statistics

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A has 606.64M shares outstanding.

Shares Outstanding606.64M

Valuation Ratios

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A trades at a trailing price-to-earnings ratio of 17.52. The price-to-sales ratio is 0.78, and the price-to-book ratio stands at 0.99.

PE Ratio17.52
PS Ratio0.78
PB Ratio0.99
P/TBV Ratio1.09

Enterprise Valuation

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A trades at an EV/EBITDA multiple of 12.38 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.62 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.38 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.28B versus a market cap of 7.90B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.62
EV / EBITDA12.38
EV / EBIT12.38

Financial Position

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.10, indicating elevated leverage, while an interest coverage ratio of 13.28 demonstrates strong ability to service its debt obligations.

Current Ratio1.45
Quick Ratio0.48
Debt / Equity13.10
Debt / EBITDA2.13
Interest Coverage13.28

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A posted a return on equity (ROE) of 5.73, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.68 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.00, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.29, useful for judging operating efficiency across full business cycles. The company generates approximately 1.27M in revenue per employee across its workforce of 7,982.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.62 indicates how many times Shinva Medical Instrument Co. Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)5.73
Return on Assets (ROA)3.00
Return on Invested Capital (ROIC)4.68
Return on Capital Employed (ROCE)5.29
Revenue Per Employee1.27M
Employee Count7,982.00
Inventory Turnover2.62

Taxes

CNY

Over the twelve months ended September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A recorded 66.56M in income tax expense. That works out to an effective tax rate of 13.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 511.02M, leaving 452.76M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax66.56M
Effective Tax Rate13.02

Stock Price Statistics

CNY

As of the close on November 17, 2026, Shinva Medical Instrument Co. Ltd. Class A's stock has declined approximately 19.96% over the past 52 weeks. The 50-day moving average sits at 12.65, while the 200-day moving average is 13.48.

52-Week Price Change-19.96%
50-Day Moving Average12.65
200-Day Moving Average13.48

Income Statement

CNY

Over the twelve months ended September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A generated 10.11B in revenue and converted that into 452.76M in net income, yielding earnings per share of 0.73. EBITDA reached 507.02M, while operating income came in at 730.05M.

Revenue10.11B
Gross Profit2.49B
Operating Income730.05M
Pretax Income511.02M
Net Income452.76M
EBITDA507.02M
EBIT507.02M
Earnings Per Share (EPS)0.73

Balance Sheet

CNY

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A holds 3.01B in cash and equivalents against 1.08B in total debt, resulting in a net debt position of -2.05B. Total book value stands at 7.94B, with working capital of 2.82B providing operational flexibility.

Cash & Cash Equivalents3.01B
Total Debt1.08B
Net Debt-2.05B
Equity (Book Value)7.94B
Book Value Per Share13.09
Working Capital2.82B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-149.70M

Margins

Over the twelve months ended September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A posted a gross margin of 24.66, reflecting its pricing power and cost economics. The operating margin of 7.22 and net profit margin of 4.48 provide insight into operational efficiency.

Gross Margin24.66
Operating Margin7.22
Pretax Margin5.05
Profit Margin4.48
EBITDA Margin5.01

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A paid dividends of 0.39 per share. The dividend payout ratio of 54.24 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 4.63, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Shinva Medical Instrument Co. Ltd. Class A shareholders.

Dividend Per Share0.39
Payout Ratio54.24
Shareholder Yield4.63

Stock Splits

Shinva Medical Instrument Co. Ltd. Class A's most recent stock split took place on June 6, 2024 with a 10:13 split ratio.

Last Split Date6/6/2024
Split Ratio10:13

Scores

As of September 30, 2026, Shinva Medical Instrument Co. Ltd. Class A has an Altman Z-Score of 2.27, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.27